The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000150:complications; D048909:Diabetes Complications; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009316:National Institutes of Health (U.S.); D010353:Patient Education as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000628:therapy; D011369:Professional-Patient Relations; D012306:Risk; D014481:United States; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D014665:Vasodilator Agents